Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck (Q33335566)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck |
scientific article |
Statements
1 reference
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck (English)
1 reference
Colnot DR
1 reference
Quak JJ
1 reference
Roos JC
1 reference
van Lingen A
1 reference
Wilhelm AJ
1 reference
van Kamp GJ
1 reference
Huijgens PC
1 reference
Snow GB
1 reference
van Dongen GA
1 reference
1 December 2000
1 reference
1 reference
41
1 reference
12
1 reference
1999-2010
1 reference
Identifiers
1 reference